Whether its working with Pharmaceutical, CRO or Biotech organisations, within the disciplines of Clinical Development, Operations & Outsourcing, Regulatory Affairs, Biometrics, Healthcare, Drug Safety, R&D, Medical Affairs & Communications, QA/QC, Manufacturing & Engineering or Health Economics, SEC Pharma can assist wherever you are looking to hire or work throughout the UK and Europe.
Established in 1995, SEC Pharma consists of a team of European, multi-lingual and highly experienced consultants who each have a background in clinical or scientific disciplines and know their markets extremely well. Our consultants work from two shared hub offices in London and Woking in the UK, however each one has a focus on a particular skill set and specific geography, depending on their technical knowledge, cultural awareness and language skills.
By familiarising ourselves with individual candidate skill sets and personalities, as well as our client’s specific business requirements and cultures, we guarantee we can match jobseekers with client roles – ensuring both organisation and individual can work to their full potential, wherever they are located. We have successfully recruited in Belgium, UK, Netherlands, France, Germany, Switzerland, Spain, Italy, Poland, Denmark, Sweden and Norway.
SEC latest news
Meet SEC Pharma at 25th DIA Annual EuroMeetingFebruary 1, 2013 - Our continued focus on Europe sees us attending the 25th DIA Annual EuroMeeting, which is taking place this year at the RAI, Amsterdam from 4-6 March. Our team are keen to meet with people from across Europe, whatever facet of the discovery, development and life cycle management of pharmaceuticals, medical devices, and related products you
SEC Pharma appoints three Associate Directors to support growth plans in 2013January 21, 2013 - SEC Pharma has just appointed three Associate Directors to drive the growth of our specialist recruitment services. With over 25 years’ recruiting experience between them, Louis Gicquel, James Carrera and James Brown were all previously consultants and, most recently, team leaders at SEC. They have all been promoted to the role of Associate Director as